These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2921271)

  • 1. Effect of continuous vs intermittent application of 3-OH-tamoxifen or tamoxifen on the proliferation of the human breast cancer cell line MCF-7 M1.
    Dietel M; Löser R; Röhlke P; Jonat W; Niendorf A; Gerding D; Kohr A; Hölzel F; Arps H
    J Cancer Res Clin Oncol; 1989; 115(1):36-40. PubMed ID: 2921271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.
    Bursch W; Ellinger A; Kienzl H; Török L; Pandey S; Sikorska M; Walker R; Hermann RS
    Carcinogenesis; 1996 Aug; 17(8):1595-607. PubMed ID: 8761415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
    Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC; Desta Z; Flockhart DA; Skaar TC
    Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared effects of GnRH analogs and 4-hydroxytamoxifen on growth and steroid receptors in antiestrogen sensitive and resistant MCF-7 breast cancer cell sublines.
    Néri C; Berthois Y; Schatz B; Drieu K; Martin PM
    Breast Cancer Res Treat; 1990 Feb; 15(2):85-93. PubMed ID: 2138918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM; Langan-Fahey SM; Parker CJ; McCague R; Jordan VC
    J Natl Cancer Inst; 1993 May; 85(10):806-12. PubMed ID: 8487325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
    Borras M; Jin L; Bouhoute A; Legros N; Leclercq G
    Biochem Pharmacol; 1994 Nov; 48(11):2015-24. PubMed ID: 7802690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM; Jiang SY; Jeng MH; Jordan VC
    Cancer Res; 1989 Aug; 49(15):4090-3. PubMed ID: 2743303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen.
    Taylor CM; Blanchard B; Zava DT
    Cancer Res; 1984 Apr; 44(4):1409-14. PubMed ID: 6704959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.
    Gee JM; Harper ME; Hutcheson IR; Madden TA; Barrow D; Knowlden JM; McClelland RA; Jordan N; Wakeling AE; Nicholson RI
    Endocrinology; 2003 Nov; 144(11):5105-17. PubMed ID: 12960029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
    Catherino WH; Wolf DM; Jordan VC
    Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N; Barberi-Heyob M; Merlin JL; Ledrich ML; Batt AM; Guillemin F
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.
    Löser R; Seibel K; Roos W; Eppenberger U
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):985-90. PubMed ID: 4043181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma cells irradiated in vitro.
    Sarkaria JN; Miller EM; Parker CJ; Jordan VC; Mulcahy RT
    Breast Cancer Res Treat; 1994; 30(2):159-65. PubMed ID: 7949215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells.
    Gundimeda U; Chen ZH; Gopalakrishna R
    J Biol Chem; 1996 Jun; 271(23):13504-14. PubMed ID: 8662863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation.
    Zheng Y; Sun D; Sharma AK; Chen G; Amin S; Lazarus P
    Drug Metab Dispos; 2007 Oct; 35(10):1942-8. PubMed ID: 17620345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estrogen receptors and antiestrogen binding sites in an early effect of antiestrogens, the inhibition of cholesterol biosynthesis.
    Cypriani B; Tabacik C; Descomps B; Crastes de Paulet A
    J Steroid Biochem; 1988 Nov; 31(5):763-71. PubMed ID: 3199816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.